Literature DB >> 19713535

Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells.

Fumihiro Sanada1, Yoshiaki Taniyama, Kazuma Iekushi, Junya Azuma, Keita Okayama, Hiroshi Kusunoki, Nobutaka Koibuchi, Takefumi Doi, Yoshifusa Aizawa, Ryuichi Morishita.   

Abstract

RATIONALE: Neointimal hyperplasia contributes to atherosclerosis and restenosis after percutaneous coronary intervention. Vascular injury in each of these conditions results in the release of mitogenic growth factors and hormones that contribute to pathological vascular smooth muscle cell growth and inflammation. Hepatocyte growth factor (HGF) is known as an antiinflammatory growth factor, although it is downregulated in injured tissue. However, the precise mechanism how HGF reduces inflammation is unclear.
OBJECTIVE: To elucidate the mechanism how HGF and its receptor c-Met reduces angiotensin II (Ang II)-induced inflammation. METHODS AND
RESULTS: HGF reduced Ang II-induced vascular smooth muscle cell growth and inflammation by controlling translocation of SHIP2 (Src homology domain 2-containing inositol 5'-phosphatase 2), which led to Ang II-dependent degradation of epithelial growth factor receptor. Moreover, the present study also revealed a preventive effect of HGF on atherosclerotic change in an Ang II infusion and cuff HGF transgenic mouse model.
CONCLUSIONS: These data suggest that the HGF/c-Met system might regulate extrinsic factor signaling that maintains the homeostasis of organs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19713535     DOI: 10.1161/CIRCRESAHA.109.202713

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  14 in total

1.  Activation of the D4 dopamine receptor attenuates proliferation and migration of vascular smooth muscle cells through downregulation of AT1a receptor expression.

Authors:  Changqing Yu; Jianghua Chen; Weiwei Guan; Yu Han; Wei Eric Wang; Xukai Wang; Hongyong Wang; Pedro A Jose; Chunyu Zeng
Journal:  Hypertens Res       Date:  2015-04-02       Impact factor: 3.872

2.  Novel role for endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms.

Authors:  Ricardo A Peña-Silva; Nohra Chalouhi; Lauren Wegman-Points; Muhammad Ali; Ian Mitchell; Gary L Pierce; Yi Chu; Zuhair K Ballas; Donald Heistad; David Hasan
Journal:  Hypertension       Date:  2014-12-15       Impact factor: 10.190

Review 3.  Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus.

Authors:  Hiroyuki Konya; Masayuki Miuchi; Kahori Satani; Satoshi Matsutani; Taku Tsunoda; Yuzo Yano; Tomoyuki Katsuno; Tomoya Hamaguchi; Jun-Ichiro Miyagawa; Mitsuyoshi Namba
Journal:  World J Diabetes       Date:  2014-10-15

4.  Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent.

Authors:  Fumihiro Sanada; Yoshiaki Taniyama; Junya Azuma; Ikeda-Iwabe Yuka; Yasuhiro Kanbara; Masaaki Iwabayashi; Hiromi Rakugi; Ryuichi Morishita
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2014-04

5.  Analysis of disease progression-associated gene expression profile in fibrillin-1 mutant mice: new insight into molecular pathogenesis of marfan syndrome.

Authors:  Koung Li Kim; Chanmi Choi; Wonhee Suh
Journal:  Biomol Ther (Seoul)       Date:  2014-02       Impact factor: 4.634

6.  Hepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in Mice.

Authors:  Jun Muratsu; Masaaki Iwabayashi; Fumihiro Sanada; Yoshiaki Taniyama; Rei Otsu; Hiromi Rakugi; Ryuichi Morishita
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

7.  Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension.

Authors:  Hiroshi Kusunoki; Yoshiaki Taniyama; Hiromi Rakugi; Ryuichi Morishita
Journal:  J Am Heart Assoc       Date:  2013-04-22       Impact factor: 5.501

8.  Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation.

Authors:  George S Karagiannis; Jochen Weile; Gary D Bader; Joe Minta
Journal:  BMC Cardiovasc Disord       Date:  2013-01-16       Impact factor: 2.298

9.  MicroRNA-210 promotes angiogenesis in acute myocardial infarction.

Authors:  Zhong-Guo Fan; Xin-Liang Qu; Peng Chu; Ya-Li Gao; Xiao-Fei Gao; Shao-Liang Chen; Nai-Liang Tian
Journal:  Mol Med Rep       Date:  2018-02-20       Impact factor: 2.952

Review 10.  Gene-Therapeutic Strategies Targeting Angiogenesis in Peripheral Artery Disease.

Authors:  Fumihiro Sanada; Yoshiaki Taniyama; Jun Muratsu; Rei Otsu; Hideo Shimizu; Hiromi Rakugi; Ryuichi Morishita
Journal:  Medicines (Basel)       Date:  2018-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.